AD

Advaxis

- NASDAQ:ADXS
Last Updated 2024-04-19
  • Advaxis is a clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases.

  • Locations

    • Princeton NJ

  • Total Funding (USD)

    128.5 million

  • Industries

    Real Estate, Software, Cyber Security, Internet

  • Security

    Type: ORD
    CUSIP: 007624208
    ISIN: US0076243072
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo